Edelman, R.;                     Assaraf, Y.G.;                     Slavkin, A.;                     Dolev, T.;                     Shahar, T.;                     Livney, Y.D.    
        Developing Body-Components-Based Theranostic Nanoparticles for Targeting Ovarian Cancer. Pharmaceutics 2019, 11, 216.
    https://doi.org/10.3390/pharmaceutics11050216
    AMA Style
    
                                Edelman R,                                 Assaraf YG,                                 Slavkin A,                                 Dolev T,                                 Shahar T,                                 Livney YD.        
                Developing Body-Components-Based Theranostic Nanoparticles for Targeting Ovarian Cancer. Pharmaceutics. 2019; 11(5):216.
        https://doi.org/10.3390/pharmaceutics11050216
    
    Chicago/Turabian Style
    
                                Edelman, Ravit,                                 Yehuda G. Assaraf,                                 Anton Slavkin,                                 Tamar Dolev,                                 Tal Shahar,                                 and Yoav D. Livney.        
                2019. "Developing Body-Components-Based Theranostic Nanoparticles for Targeting Ovarian Cancer" Pharmaceutics 11, no. 5: 216.
        https://doi.org/10.3390/pharmaceutics11050216
    
    APA Style
    
                                Edelman, R.,                                 Assaraf, Y. G.,                                 Slavkin, A.,                                 Dolev, T.,                                 Shahar, T.,                                 & Livney, Y. D.        
        
        (2019). Developing Body-Components-Based Theranostic Nanoparticles for Targeting Ovarian Cancer. Pharmaceutics, 11(5), 216.
        https://doi.org/10.3390/pharmaceutics11050216